Literature DB >> 25797231

Fetal ultrasound markers of severity predict resolution of pulmonary hypertension in congenital diaphragmatic hernia.

Leslie A Lusk1, Katherine C Wai2, Anita J Moon-Grady3, Amaya M Basta4, Roy Filly4, Roberta L Keller5.   

Abstract

OBJECTIVE: Congenital diaphragmatic hernia (CDH) results in morbidity and death from lung hypoplasia and persistent pulmonary hypertension (PH). We sought to define the relationship between fetal ultrasound markers of severity in CDH and the time to resolution of neonatal PH. STUDY
DESIGN: We conducted a retrospective study of fetuses with an antenatal ultrasound scan and left-sided CDH cared for at the University of California San Francisco (2002-2012). Fetal liver position was classified on ultrasound scan as abdominal (entire liver within the abdomen) or thoracic (any portion of the liver within the thorax). Fetal stomach position was classified from least to most aberrant: abdominal, anterior left chest, mid-posterior left chest, or retrocardiac (right chest). Lung-to-head ratio (LHR) was determined from available scans at 20-29 weeks of gestational age (GA). Routine neonatal echocardiograms were performed weekly for up to 6 weeks or until PH resolved or until discharge. PH was assessed by echocardiogram with the use of a hierarchy of ductus arteriosus level shunt, interventricular septal position, and tricuspid regurgitant jet velocity. Days to PH-free survival was defined as the age at which pulmonary artery pressure was estimated to be <2/3 systemic blood pressure. Cox proportional hazards models adjusted for GA at birth, era of birth, fetal surgery, and GA at ultrasound scan (LHR model only), with censoring at 100 days.
RESULTS: Of 118 patients, the following fetal markers were available: LHR (n = 53), liver position (n = 112), and stomach position (n = 80). Fewer infants experienced resolved PH if they had LHR <1 (P = .006), thoracic liver position (P = .001), or more aberrant stomach position (P < .001). There was also a decreased rate of resolution of PH in infants with LHR <1 (hazard ratio, 0.30; P = .007), thoracic liver position (hazard ratio, 0.38; P < .001), and more aberrant stomach position (hazard ratios, 0.28 [P = .002]; 0.1 [P < .001]; and 0.07 [P < .001]).
CONCLUSION: Fetal ultrasound markers of CDH severity are predictive not only of death but also of significant morbidity. LHR <1, thoracic liver, and aberrant stomach position are associated with delayed time to resolution of PH in infants with CDH and may be used to identify fetuses at high risk of persistent PH.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lung-to-head ratio; pulmonary vascular resistance; ultrasound marker

Mesh:

Year:  2015        PMID: 25797231      PMCID: PMC4519413          DOI: 10.1016/j.ajog.2015.03.036

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  39 in total

1.  Predictors of the need for extracorporeal membrane oxygenation and survival in congenital diaphragmatic hernia: a center's 10-year experience.

Authors:  Anthony O Odibo; Tasnim Najaf; Akshaya Vachharajani; Barbara Warner; Amit Mathur; Brad W Warner
Journal:  Prenat Diagn       Date:  2010-06       Impact factor: 3.050

Review 2.  Value of liver herniation in prediction of outcome in fetal congenital diaphragmatic hernia: a systematic review and meta-analysis.

Authors:  D Mullassery; M E Ba'ath; E C Jesudason; P D Losty
Journal:  Ultrasound Obstet Gynecol       Date:  2010-05       Impact factor: 7.299

3.  Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia.

Authors:  J Jani; K H Nicolaides; R L Keller; A Benachi; C F A Peralta; R Favre; O Moreno; D Tibboel; S Lipitz; A Eggink; P Vaast; K Allegaert; M Harrison; J Deprest
Journal:  Ultrasound Obstet Gynecol       Date:  2007-07       Impact factor: 7.299

4.  Liver position and lung-to-head ratio for prediction of extracorporeal membrane oxygenation and survival in isolated left congenital diaphragmatic hernia.

Authors:  Holly L Hedrick; Enrico Danzer; Aziz M Merchant; Michael W Bebbington; Huaqing Zhao; Alan W Flake; Mark P Johnson; Kenneth W Liechty; Lori J Howell; R Douglas Wilson; N Scott Adzick
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 5.  Prenatal detection of pulmonary hypoplasia in fetuses with congenital diaphragmatic hernia: a systematic review and meta-analysis of diagnostic studies.

Authors:  Ellen Knox; David Lissauer; Khalid Khan; Mark Kilby
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

6.  Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study.

Authors:  J C Jani; A Benachi; K H Nicolaides; K Allegaert; E Gratacós; R Mazkereth; J Matis; D Tibboel; A Van Heijst; L Storme; V Rousseau; A Greenough; J A Deprest
Journal:  Ultrasound Obstet Gynecol       Date:  2009-01       Impact factor: 7.299

7.  Learning curve for lung area to head circumference ratio measurement in fetuses with congenital diaphragmatic hernia.

Authors:  R Cruz-Martinez; F Figueras; O Moreno-Alvarez; J M Martinez; O Gomez; E Hernandez-Andrade; E Gratacos
Journal:  Ultrasound Obstet Gynecol       Date:  2010-07       Impact factor: 7.299

Review 8.  Antenatal and postnatal lung and vascular anatomic and functional studies in congenital diaphragmatic hernia: implications for clinical management.

Authors:  Roberta L Keller
Journal:  Am J Med Genet C Semin Med Genet       Date:  2007-05-15       Impact factor: 3.908

9.  Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity.

Authors:  Roberta L Keller; Theresa A Tacy; Karen Hendricks-Munoz; Jie Xu; Anita J Moon-Grady; John Neuhaus; Phillip Moore; Kerilyn K Nobuhara; Sam Hawgood; Jeffrey R Fineman
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

10.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

View more
  5 in total

1.  Prenatal Diagnosis of Congenital Diaphragmatic Hernia: Does Laterality Predict Perinatal Outcomes?

Authors:  Jeffrey D Sperling; Teresa N Sparks; Victoria K Berger; Jody A Farrell; Kristen Gosnell; Roberta L Keller; Mary E Norton; Juan M Gonzalez
Journal:  Am J Perinatol       Date:  2018-01-05       Impact factor: 1.862

2.  Fetal echocardiography (ECHO) in assessment of structural heart defects in congenital diaphragmatic hernia patients: Is early postnatal ECHO necessary for ECMO candidacy?

Authors:  Candace C Style; Oluyinka O Olutoye; Mariatu A Verla; Keila N Lopez; Adam M Vogel; Patricio E Lau; Stephanie M Cruz; Jimmy Espinoza; Caraciolo J Fernandes; Sundeep G Keswani; Timothy C Lee
Journal:  J Pediatr Surg       Date:  2019-02-20       Impact factor: 2.545

3.  Sepsis risk factors in infants with congenital diaphragmatic hernia.

Authors:  Michaël Levy; Nolwenn Le Sache; Mostafa Mokhtari; Guy Fagherazzi; Gaelle Cuzon; Benjamin Bueno; Virginie Fouquet; Alexandra Benachi; Sergio Eleni Dit Trolli; Pierre Tissieres
Journal:  Ann Intensive Care       Date:  2017-03-21       Impact factor: 6.925

4.  Randomized Trial of Fetal Surgery for Moderate Left Diaphragmatic Hernia.

Authors:  Jan A Deprest; Alexandra Benachi; Eduard Gratacos; Kypros H Nicolaides; Christoph Berg; Nicola Persico; Michael Belfort; Glenn J Gardener; Yves Ville; Anthony Johnson; Francesco Morini; Mirosław Wielgoś; Ben Van Calster; Philip L J DeKoninck
Journal:  N Engl J Med       Date:  2021-06-08       Impact factor: 176.079

5.  Prenatal stomach position and volume in relation to postnatal outcomes in left-sided congenital diaphragmatic hernia.

Authors:  Katinka Weller; Nina C J Peters; Joost van Rosmalen; Suzan C M Cochius-Den Otter; Philip L J DeKoninck; Rene M H Wijnen; Titia E Cohen-Overbeek; Alex J Eggink
Journal:  Prenat Diagn       Date:  2021-07-28       Impact factor: 3.242

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.